CAS 33396-29-1

(2S,3R,4S,5S,8R,9S,10S,11R,12R)-11-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-5-ethyl-3,4-dihydroxy-9-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-2,4,8,10,12,14-hexamethyl-6,15-dioxa

Description:

The chemical substance with the name "(2S,3R,4S,5S,8R,9S,10S,11R,12R)-11-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-5-ethyl-3,4-dihydroxy-9-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-2,4,8,10,12,14-hexamethyl-6,15-dioxa" and CAS number "33396-29-1" is a complex organic molecule characterized by multiple stereocenters, indicating a high degree of chirality. This compound features a variety of functional groups, including hydroxyl (-OH), methoxy (-OCH3), and dimethylamino (-N(CH3)2) groups, which contribute to its potential biological activity. The presence of multiple tetrahydropyran rings suggests it may exhibit interesting interactions in biological systems, possibly influencing its solubility and reactivity. The hexamethyl and ethyl substituents indicate a bulky structure, which could affect its pharmacokinetics and binding affinity in biological contexts. Overall, this compound's intricate structure and functional diversity suggest it may have applications in medicinal chemistry or as a lead compound for further drug development.

Formula: C₃₇H₆₅NO₁₂

InChI: InChI=1/C37H65NO12/c1-14-25-37(10,43)30(40)20(4)28-18(2)16-36(9,50-28)32(49-34-27(39)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)47-25)48-26-17-35(8,44-13)31(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20-,21+,22-,23+,24+,25+,26+,27-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1

Erythromycin A enol ether

CAS: 33396-29-1

Erythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.

Formula: C₃₇H₆₅NO₁₂

Purity: 99.94%

Color and Shape: Solid

Molecular weight: 715.91

Ref: TM-T21572

Erythromycin A enol ether

CAS: 33396-29-1

Erythromycin A enol ether

Purity: ≥98%

Molecular weight: 715.91g/mol

Ref: 54-BUP12120

Erythromycin EP Impurity E (Erythromycin A Enol Ether)

CAS: 33396-29-1

Formula: C₃₇H₆₅NO₁₂

Color and Shape: White To Off-White Solid

Molecular weight: 715.92

Ref: 4Z-E-2022

Erythromycin EP Impurity E

CAS: 33396-29-1

Formula: C₃₇H₆₅NO₁₂

Molecular weight: 715.92

Ref: ST-EA-CP-E18005

Erythromycin A Enol Ether

CAS: 33396-29-1

Impurity Erythromycin EP Impurity E
Applications Erythromycin A Enol Ether (Erythromycin EP Impurity E) is an impurity of Erythromycin.
References McGuire, J.M., et al.: Antibiot. Chemother., 6, 281 (1952), Steffansen, B., et al.: Int. J. Pharm., 56, 159 (1989), Goldman, R.C., et al.: Antimicrob. Agents Chemother., 34, 1973 (1990),

Formula: C₃₇H₆₅NO₁₂

Color and Shape: Light Yellow

Molecular weight: 715.91

Ref: TR-E649970

Erythromycin A enol ether

CAS: 33396-29-1

Erythromycin A enol ether is an antimicrobial agent that is used as an antiretroviral therapy for HIV. It has been shown to be active against microbial infections caused by resistant microorganisms, such as methicillin-resistant Staphylococcus aureus and erythromycin-resistant Enterobacteriaceae. Erythromycin A enol ether has been found to be a promising candidate for topical applications due to its low toxicity and ability to penetrate the skin. The metabolite of erythromycin A enol ether is formed through hydrolysis with hydrochloric acid in the presence of glycol ester. The resulting product, erythromycin A, is an antibiotic that inhibits bacterial growth by blocking peptide synthesis at the ribosome level.

Formula: C₃₇H₆₅NO₁₂

Purity: Min. 95%

Molecular weight: 715.91 g/mol

Ref: 3D-FE22798